Partnering

Accelerating
Scientific Innovation

TCG Labs Soleil is a trusted partner for pharma and biotech companies seeking to strategically add de-risked, transformative therapeutics to their pipelines.

Proven Scientific Leadership

With decades of experience in taking therapies from discovery to the clinic, our team has successfully developed blockbuster drugs like Repatha®, Evenity®, and Prolia®. We offer the unparalleled expertise needed to move therapeutics from concept to clinical validation.

Efficient Drug Development Model

A world-class R&D team in South San Francisco prioritizes and resources the best ideas, with dedicated funds enabling us to advance programs through human proof of concept before transitioning to partners for late-stage development and commercialization.

Opportunity for Selective Acquisitions

We select these programs based on compelling biology, unmet need, as well as a deep understanding of biopharma priorities, to enable each one to bring value to our partners.

Robust Pipeline

We are advancing candidates across multiple therapeutic areas, with a variety of modalities that present attractive opportunities for strategic transactions.

Pipeline

A Pipeline Ready to Integrate with Yours

Portfolio Company
Disease Area
Stage
Portfolio Company Juri Biosciences, Inc.
Disease Area Oncology
Stage IND-enabling
Portfolio Company Duboce Biopharmaceuticals, Inc.
Disease Area Oncology
Stage IND-Enabling
Portfolio Company Arguello Biosciences, Inc.
Disease Area Cardiovascular
Stage IND-enabling
Portfolio Company Fulton Therapeutics, Inc.
Disease Area Immunology
Stage IND-enabling
Portfolio Company Clement Therapeutics, Inc.
Disease Area Immunology
Stage Preclinical
Portfolio Company Highland Therapeutics, Inc.
Disease Area Neurology
Stage Preclinical
Portfolio Company Balboa Biopharmaceuticals, Inc.
Disease Area Immunology
Stage Preclinical
Portfolio Company Irving Life Sciences, Inc.
Disease Area Oncology
Stage Preclinical
Portfolio Company Natoma Biosciences, Inc.
Disease Area Obesity
Stage Preclinical
Contact Us

Strategic Solutions, Shared Goals

TCG Labs Soleil makes it easy to acquire therapeutic programs that fit your goals. You can follow the progress of our portfolio companies and engage with us when the time is right. If our current portfolio doesn’t align with your priorities, we welcome the opportunity to discuss how our model can add value to your pipeline.

Together, we combine your vision with our scientific expertise and R&D capabilities to accelerate the development of next-generation therapeutics for patients with unmet medical needs.